Dilation of Epicardial Coronary Arteries by the G Protein-Coupled Estrogen Receptor Agonists G-1 and ICI 182,780

被引:102
作者
Meyer, Matthias R. [1 ,2 ]
Baretella, Oliver [1 ]
Prossnitz, Eric R. [3 ,4 ]
Barton, Matthias [1 ]
机构
[1] Univ Zurich, CH-8057 Zurich, Switzerland
[2] Triemli City Hosp, Dept Internal Med, Zurich, Switzerland
[3] Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA
[4] Univ New Mexico, Hlth Sci Ctr, Univ New Mexico Canc Ctr, Albuquerque, NM 87131 USA
基金
瑞士国家科学基金会;
关键词
Atherosclerosis; Coronary artery disease; Estrogen; Faslodex; Fulvestrant; Myocardial infarction; Vasodilation; ENDOTHELIUM-INDEPENDENT RELAXATION; NITRIC-OXIDE; IN-VITRO; CONTRACTILE RESPONSES; DEPENDENT MECHANISM; PURE-ANTIESTROGEN; BREAST-CANCER; FEMALE PIGS; 17-BETA-ESTRADIOL; BETA;
D O I
10.1159/000315497
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Endogenous estrogens protect from coronary artery disease in premenopausal women, but the mechanisms involved are only partly understood. This study investigated whether activation of the novel G protein-coupled estrogen receptor (GPER, formerly known as GPR30) affects coronary artery tone, and whether this is affected by concomitant blockade of estrogen receptors (ER) alpha and beta. Rings of epicardial porcine coronary arteries suspended in organ chambers were precontracted with prostaglandin F-2 alpha, and direct effects of G-1 (GPER agonist) and ICI 182,780 (GPER agonist and ER alpha/ER beta antagonist) were determined. In addition, indirect effects on contractility to endothelin-1 and serotonin (a vasoconstrictor released from aggregating platelets during acute myocardial infarction) were assessed. ICI 182,780 and G-1 caused acute dilation of coronary arteries to a comparable degree (p < 0.05 vs. solvent control). Both GPER agonists attenuated contractions to endothelin-1 (p < 0.05 vs. ethanol), but not to serotonin (n.s.). In summary, these findings provide evidence for direct and indirect coronary artery dilator effects of GPER independent of ER alpha and ER beta, and are the first demonstration of arterial vasodilation in response to ICI 182,780. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:58 / 64
页数:7
相关论文
共 45 条
[1]   Virtual and biomolecular screening converge on a selective agonist for GPR30 [J].
Bologa, CG ;
Revankar, CM ;
Young, SM ;
Edwards, BS ;
Arterburn, JB ;
Kiselyov, AS ;
Parker, MA ;
Tkachenko, SE ;
Savchuck, NP ;
Sklar, LA ;
Oprea, TI ;
Prossnitz, ER .
NATURE CHEMICAL BIOLOGY, 2006, 2 (04) :207-212
[2]   A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury [J].
Bopassa, Jean Chrisostome ;
Eghbali, Mansoureh ;
Toro, Ligia ;
Stefani, Enrico .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2010, 298 (01) :H16-H23
[3]   Acute effects of 17β-estradiol on femoral veins from adult gonadally intact and ovariectomized female pigs [J].
Bracamonte, MP ;
Jayachandran, M ;
Rud, KS ;
Miller, VM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 283 (06) :H2389-H2396
[4]   Endothelial-derived superoxide anions in pig coronary arteries: Evidence from lucigenin chemiluminescence and histochemical techniques [J].
Brandes, RP ;
Barton, M ;
Philippens, KMH ;
Schweitzer, G ;
Mugge, A .
JOURNAL OF PHYSIOLOGY-LONDON, 1997, 500 (02) :331-342
[5]   Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries [J].
Broughton, Brad R. S. ;
Miller, Alyson A. ;
Sobey, Christopher G. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2010, 298 (03) :H1055-H1061
[6]   17-β-oestradiol-induced vasorelaxation in vitro is mediated by eNOS through hsp90 and akt/pkb dependent mechanism [J].
Bucci, M ;
Roviezzo, F ;
Cicala, C ;
Pinto, A ;
Cirino, G .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (07) :1695-1700
[7]   Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen [J].
Chen, Z ;
Yuhanna, IS ;
Galcheva-Gargova, Z ;
Karas, RH ;
Mendelsohn, RE ;
Shaul, PW .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (03) :401-406
[8]   Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial Results of Subgroup Analyses by Age and Other Factors [J].
Collins, Peter ;
Mosca, Lori ;
Geiger, Mary Jane ;
Grady, Deborah ;
Kornitzer, Marcel ;
Amewou-Atisso, Messan G. ;
Effron, Mark B. ;
Dowsett, Sherie A. ;
Barrett-Connor, Elizabeth ;
Wenger, Nanette K. .
CIRCULATION, 2009, 119 (07) :922-930
[9]   Lasofoxifene in Postmenopausal Women with Osteoporosis [J].
Cummings, Steven R. ;
Ensrud, Kristine ;
Delmas, Pierre D. ;
LaCroix, Andrea Z. ;
Vukicevic, Slobodan ;
Reid, David M. ;
Goldstein, Steven ;
Sriram, Usha ;
Lee, Andy ;
Thompson, John ;
Armstrong, Roisin A. ;
Thompson, David D. ;
Powles, Trevor ;
Zanchetta, Jose ;
Kendler, David ;
Neven, Patrick ;
Eastell, Richard .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (08) :686-696
[10]  
DELEAN A, 1978, AM J PHYSIOL, V235, P97